Iguratimod inhibits osteoclastogenesis by modulating the RANKL and TNF-α signaling pathways-Reference-Cited by-同舟云学术

Iguratimod inhibits osteoclastogenesis by modulating the RANKL and TNF-α signaling pathways

Published:2021-01 Issue: Volume:90 Page:107219
ISSN:1567-5769
Container-title:International Immunopharmacology
language:en
Short-container-title:International Immunopharmacology

Author:

Li Chang-hong,Ma Zhen-zhen,Jian Lei-lei,Wang Xin-yu,Sun Lin,Liu Xiang-yuan,Yao Zhong-qiang,Zhao Jin-xia

Funder

National Natural Science Foundation of China

Publisher

Elsevier BV

Subject

Pharmacology,Immunology,Immunology and Allergy

Reference54 articles.

1. Pathogenetic insights from the treatment of rheumatoid arthritis;McInnes;The Lancet,2017

2. Periarticular bone structure in rheumatoid arthritis patients and healthy individuals assessed by high-resolution computed tomography;Stach;Arthritis Rheum.,2010

3. Bone mineral density and frequency of osteoporosis in female patients with rheumatoid arthritis: results from 394 patients in the Oslo County Rheumatoid Arthritis register;Haugeberg;Arthritis Rheum.,2000

4. Joint Erosions and Patients with Early Rheumatoid Arthritis;van der Heijde;Rheumatology,1995

5. Course of radiographic damage over 10 years in a cohort with early rheumatoid arthritis;Lindqvist;Ann. Rheum. Dis.,2003

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Iguratimod suppresses sclerostin and receptor activator of NF-κB ligand production via the extracellular signal–regulated kinase/early growth response protein 1/tumor necrosis factor alpha pathway in osteocytes and ameliorates disuse osteoporosis in mice;Bone;2024-02

2. Nitazoxanide reduces inflammation and bone erosion in mice with collagen-induced arthritis via inhibiting the JAK2/STAT3 and NF-κB pathways in fibroblast-like synoviocytes;Biomedicine & Pharmacotherapy;2024-02

3. Research progress of hexokinase 2 in inflammatory-related diseases and its inhibitors;European Journal of Medicinal Chemistry;2024-01

4. Synergistic therapeutic antitumor effect of PD-1 blockade cellular vesicles in combination with Iguratimod and Rhodium nanoparticles;Journal of Colloid and Interface Science;2023-11

5. A novel drug combination of Tofacitinib and Iguratimod alleviates rheumatoid arthritis and secondary osteoporosis;International Immunopharmacology;2023-11